Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

DIGITAL CONTENT

25 NEWS #PharmaBuzz

media
25 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

24DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 203737-93-3, Istaroxime, (e)-, Pst-2744, W40687go3s, (3e,5s,8r,9s,10r,13s,14s)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione, 203738-46-9

Molecular Formula

C₂₁H₃₂N₂O₃

Molecular Weight

360.5 g/mol

InChI Key

MPYLDWFDPHRTEG-PAAYLBSLSA-N

FDA UNII

W40687GO3S

1 2D Structure

Istaroxime

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3E,5S,8R,9S,10R,13S,14S)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione

2.1.2 InChI

InChI=1S/C21H32N2O3/c1-20-7-5-13(23-26-10-9-22)11-17(20)18(24)12-14-15-3-4-19(25)21(15,2)8-6-16(14)20/h14-17H,3-12,22H2,1-2H3/b23-13+/t14-,15-,16-,17+,20+,21-/m0/s1

2.1.3 InChI Key

MPYLDWFDPHRTEG-PAAYLBSLSA-N

2.1.4 Canonical SMILES

CC12CCC(=NOCCN)CC1C(=O)CC3C2CCC4(C3CCC4=O)C

2.1.5 Isomeric SMILES

C[C@]12CC/C(=N\OCCN)/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C

2.2 Other Identifiers

2.2.1 UNII

W40687GO3S

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 3-((2-aminoethoxy)imino)androstane-6,17-dione

2. 3-((2-aminoethoxy)imino)androstane-6,17-dione Hydrochloride

3. Pst 2744

4. Pst-2744

5. Pst2744

2.3.2 Depositor-Supplied Synonyms

1. 203737-93-3

2. Istaroxime, (e)-

3. Pst-2744

4. W40687go3s

5. (3e,5s,8r,9s,10r,13s,14s)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione

6. 203738-46-9

7. 3-((2-aminoethoxy)imino)-5alpha-androstan-6,17-dione

8. Debio-0614

9. Istaroxime [inn]

10. Unii-w8i9h2tppl

11. Pst 2744

12. St-2744

13. W8i9h2tppl

14. Unii-w40687go3s

15. Chembl469045

16. Schembl7285904

17. Dtxsid20870222

18. Akos024259258

19. Cs-1531

20. Db06157

21. Ac-36855

22. As-78198

23. Hy-15718

24. 5-alpha-androstan-6,17-dione, 3-((2-aminoethoxy)imino)-

25. Androstane-3,6,17-trione, 3-(o-(2-aminoethyl)oxime), (3e,5alpha)-

26. Androstane-3,6,17-trione, 3-(o-(2-aminoethyl)oxime), (3e,5.alpha.)-

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₃₂N₂O₃
Molecular Weight	360.5 g/mol
XLogP3	1.5
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	3
Exact Mass	360.24129289 g/mol
Monoisotopic Mass	360.24129289 g/mol
Topological Polar Surface Area	81.8 Å²
Heavy Atom Count	26
Formal Charge	0
Complexity	645
Isotope Atom Count	0
Defined Atom Stereocenter Count	6
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Investigated for use/treatment in heart disease.

5 Pharmacology and Biochemistry

5.1 Mechanism of Action

Reduces the sodium-potassium adenosine triphosphatase (ATPase) activity and stimulates the sarcoplasmic calcium ATPase isoform 2 reuptake function.

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

ABOUT THIS PAGE

Find Istaroxime manufacturers, exporters & distributors on PharmaCompass

Istaroxime

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

DEVELOPMENTS

24 Drugs in Development

DIGITAL CONTENT

25 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

24DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?